Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

Clinical trial NCT00742482 · TERMINATED

Trial details

NCT number: NCT00742482
Sponsor: LEO Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lung Injury Acute Respiratory Distress Syndrome

Start date: 2003-01-01
Primary completion: 2005-01-01
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.